Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Nextech Invest, Ltd. (CIK 1595430) reported $1.42B across 17 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: RVMD ($739.2M, 52.02%), TYRA ($155.3M, 10.93%), TNGX ($152.0M, 10.70%), ORIC ($90.8M, 6.39%), ALMS ($78.0M, 5.49%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | $739.2M | 52.02% | 7.6M | Hold |
| 2 | TYRA | TYRA BIOSCIENCES INC | $155.3M | 10.93% | 4.1M | Hold |
| 3 | TNGX | TANGO THERAPEUTICS INC | $152.0M | 10.70% | 7.3M | Hold |
| 4 | ORIC | ORIC PHARMACEUTICALS INC | $90.8M | 6.39% | 7.2M | Hold |
| 5 | ALMS | ALUMIS INC | $78.0M | 5.49% | 3.5M | Added |
| 6 | RLAY | RELAY THERAPEUTICS INC | $55.0M | 3.87% | 5.5M | Added |
| 7 | ZYME | ZYMEWORKS INC | $27.9M | 1.96% | 1.1M | Hold |
| 8 | KYMR | KYMERA THERAPEUTICS INC | $23.2M | 1.63% | 278,896 | Hold |
| 9 | CTMX | CYTOMX THERAPEUTICS INC. | $20.9M | 1.47% | 4.4M | New |
| 10 | CNTX | CONTEXT THERAPEUTICS INC | $19.4M | 1.37% | 7.4M | Hold |
| 11 | CGEM | CULLINAN THERAPEUTICS INC | $16.2M | 1.14% | 1.1M | Hold |
| 12 | ENGN | ENGENE HOLDINGS INC | $15.8M | 1.11% | 2.3M | Added |
| 13 | CRVS | CORVUS PHARMACEUTICALS INC | $6.6M | 0.46% | 450,000 | New |
| 14 | ARVN | ARVINAS INC | $5.7M | 0.40% | 539,394 | Hold |
| 15 | GLUE | MONTE ROSA THERAPEUTICS INC | $5.0M | 0.35% | 304,237 | Added |
| 16 | SLN | SILENCE THERAPEUTICS PLC | $5.0M | 0.35% | 952,400 | Hold |
| 17 | SPRY | ARS PHARMACEUTICALS INC | $4.9M | 0.35% | 610,703 | Trimmed |
| 18 | MRSN | MERSANA THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31